SLC2A3 and neoplasm: For instance, Xu et al.[47] employed an ionic lipid‐assisted PEG‐PLA nanoparticle system to effectively deliver specific GLUT3 siRNA to the tumor site, significantly reducing the metabolism and proliferative capacity of tumor cells.